Product Information
ROPINIROLE HCL 0.25 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0462 per EA under NDC 43547026850. Its NADAC has been published 651 times since Jan 8, 2014.
Strength
.25 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547026850
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078110On Market Since
9/20/2011
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 0.25 MG TABLET has been published 651 times since Jan 8, 2014, and over the history we have for it it has declined 62.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0462 per EA |
|---|---|
| All-time high | $0.1260 (Mar 12, 2014) |
| All-time low | $0.0347 (Nov 20, 2024) |
| 52-week high | $0.0476 |
| 52-week low | $0.0462 |
| Median price | $0.0648 |
| Average price | $0.0715 |
| Largest weekly change | -28.4% (Nov 20, 2024) |
| Weeks tracked | 651 |
| Tracking since | Jan 8, 2014 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 0.25 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0462 per EA (NDC 43547026850), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 0.25 MG TABLET has declined 62.6%. It has been tracked across 651 weekly CMS publications since Jan 8, 2014.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 0.25 MG TABLET?
Since Jan 8, 2014, the NADAC for ROPINIROLE HCL 0.25 MG TABLET has ranged from a low of $0.0347 (Nov 20, 2024) to a high of $0.1260 (Mar 12, 2014), with a median of $0.0648 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 0.25 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ROPINIROLE HCL 0.25 MG TABLET, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 0.25 MG TABLET?
ROPINIROLE HCL 0.25 MG TABLET (NDC 43547026850) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification